| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.vineetlabs.co.in | |
| Market Cap | 51.03 Cr. | |
| Enterprise Value(EV) | 78.17 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.03 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 53.54 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 32.44 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 32.03 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 1.73 | Calculated using Price: 55.35 |
| Dividend Yield | 1.81 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.92 Cr. | 9,219,008 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company is engaged in the business of Drug Intermediates & Bulk Dugs. | ||
| 1 Day |
|
-2.05% |
| 1 Week |
|
-3.51% |
| 1 Month |
|
-9.01% |
| 3 Month |
|
-21.19% |
| 6 Month |
|
-10.05% |
| 1 Year |
|
-23.44% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -2.87 | 13.18 | 22.19 | |||
| Return on Capital Employed (%) | -2.87 | 34.06 | 23.30 | |||
| Return on Assets (%) | -2.72 | 3.26 | 5.48 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 0 | 0 | 0 | 27 | 33 | 30 | |
| Non Curr. Liab. | 7 | 5 | 10 | ||||
| Curr. Liab. | 0 | 0 | 75 | 95 | 76 | ||
| Minority Int. | |||||||
| Equity & Liab. | 0 | 0 | 0 | 109 | 134 | 116 | |
| Non Curr. Assets | 22 | 31 | 26 | ||||
| Curr. Assets | 0 | 0 | 0 | 86 | 103 | 90 | |
| Misc. Exp. not W/O | 0 | 0 | |||||
| Total Assets | 0 | 0 | 0 | 109 | 134 | 116 |
| Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 243 | 191 | 182 | ||||
| Other Income | 0 | 0 | 0 | ||||
| Total Income | 244 | 191 | 182 | ||||
| Total Expenditure | 0 | -235 | -178 | -174 | |||
| PBIDT | 0 | 9 | 14 | 9 | |||
| Interest | -3 | -2 | -3 | ||||
| Depreciation | -2 | -2 | -2 | ||||
| Taxation | -2 | -3 | -2 | ||||
| Exceptional Items | |||||||
| PAT | 0 | 2 | 7 | 1 | |||
| Adjusted EPS | 0 | 2 | 7 | 0 |
| Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 27 | 8 | ||||
| Cash Fr. Inv. | -8 | -4 | ||||
| Cash Fr. Finan. | 19 | 14 | ||||
| Net Change | 38 | 18 | ||||
| Cash & Cash Eqvt | 38 | 56 |
|
Wed, 04 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31-12-2022 |
|
Fri, 30 Dec 2022
Closure of Trading Window This is to inform that pursuant to the SEBI (Prohibition of lnsider Trading) Regulations 2015 read with the Companys Code of Conduct for regulate monitor and report trading by Insiders and Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information the Trading Window for dealing in the securities of the Company will remain closed from 01st January 2023 till 48 hours after the announcement of unaudited financial results for the third quarter & nine months ended 31st December 2022 for all designated persons their immediate relatives and all connected persons covered under the said Code. |
|
Tue, 29 Nov 2022
Disclosure Of Related Party Transactions For The Half Year Ended On September 30 2022 As required under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are hereby submitting the related party transactions for the half year ended on September 30 2022. |
| Thu, 02 Feb 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors